Skip to content

Clinical trials

Phase 1 Neuromyelitis Optica trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuromyelitis Optica Phase: Phase 1 Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20132
20141
20151
20161
20171
20181
20203
20222
20232
20243
20254
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting8
Not yet recruiting5
Withdrawn3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Tongji Hospital3
Chinese PLA General Hospital2
Johns Hopkins University2
Tianjin Huanhu Hospital2
Abide Therapeutics1
Bio-Thera Solutions1
Guangzhou Lupeng Pharmaceutical Company LTD.1
Harbour BioMed (Guangzhou) Co. Ltd.1
Huashan Hospital1
Michael Levy1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuromyelitis Optica27
Multiple Sclerosis13
Myasthenia Gravis9
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating5
Autoimmune Diseases of the Nervous System4
Lupus Erythematosus, Systemic3
Myelitis, Transverse3
Myositis3
Scleroderma, Systemic3
Optic Neuritis2

Trials

Showing 26 to 27 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.